The results suggested that plasma MTBR-tau243 could help estimate the tauopathy load in Alzheimer's disease, improving ...

AVB-101 is designed to halt disease progression by delivering a functional progranulin (GRN) gene. It was administered to a patient with frontotemporal dementia (FTD) carrying GRN gene mutations ...

NKGen's ongoing efforts with troculeucel aim to provide novel therapeutic approaches for FTD and other neurodegenerative diseases, where neuroinflammation plays a key role in disease progression.

a disease progression biomarker, as compared to published natural history Enrolled first FTD-GRN patient to be treated with Dose 2 PBFT02, 50% lower than Dose 1 Expect to report 12-month data from ...